BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$293.85 USD
-1.88 (-0.64%)
Updated May 17, 2024 04:00 PM ET
After-Market: $293.95 +0.10 (0.03%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $2.10 | 0.00% |
Earnings Summary
For their last quarter, BioRad Laboratories (BIO) reported earnings of $2.29 per share, beating the Zacks Consensus Estimate of $2.04 per share. This reflects a positive earnings surprise of 12.25%. Look out for BIO's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $2.10 per share, reflecting a year-over-year decrease of 30%.
Earnings History
Price & Consensus
Zacks News for BIO
Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates
BIO: What are Zacks experts saying now?
Zacks Private Portfolio Services